newsitem

On April 17th Nanomerics CEO Andreas Schatzlein attended a BIA Roundtable Discussion hosted by George Freeman MP, Government Life Sciences Adviser. The meeting will examine "What can France and the UK learn from each other in Life Sciences?".

Nanomerics CSO Professor Ijeoma F. Uchegbu has been appointed to the EPSRC's Healthcare Technologies Strategic Advisory Team.  Her appointment is with effect from 1st of April 2013.  The EPSRC's Strategic Advisory Teams provide the EPSRC with expert advice on its research and training strategy across its portfolio.

Four innovative UK life science companies will have the chance to promote their businesses and create new connections after winning the recent UK Trade and Investment (UKTI) Innovation Competition.

As one of the winning companies Nanomerics will showcase their life science technologies to an international audience at the upcoming BIO 2013 Convention in Chicago.  Nanomerics receives up to £1,500 towards flights and accommodation, and one year’s complimentary membership of the BioIndustry Association (BIA).

UCL News reports on the development of nano fibres as brain agents for the delivery of drugs across the blood brain barrier. The technology was developed by the team around Nanomerics CSO Prof Uchegbu and provides a new approach to the delivery of peptides to the brain. This technology extends Nanomerics portfolio of technologies that can be applied to it Pharmaceutics Discovery approach to the develpment of novel medicines based on known compounds.

It is notoriously hard to deliver therapies to the brain, primarily because of the presence of the blood brain barrier. Nanomerics scientists report peptide nanofibers may provide a new approach to deliver medicines to the brain.

The scientific journal Nanomedicine reports on Nanomerics' technology. Free full text can be found here.